Argentarii’s Vera Therapeutics VERA Stock Holding History

Argentarii’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,330	Closed	-$219K	–	215
2025 Q4	$219K	Buy	+4,330	New	+$154K	0.07%	186

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argentarii's VERA Position: Q1 2026 in Review

Argentarii sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 4,330 shares — an estimated $219K sold.

Argentarii first reported a position in VERA in Q4 2025 and held it in 1 quarter. The position peaked at $219K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

Argentarii reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
Argentarii sold 4,330 Vera Therapeutics shares in Q1 2026, an estimated $219K.
Argentarii first reported a position in Vera Therapeutics in Q4 2025 and held it in 1 quarter.
Argentarii's Vera Therapeutics position peaked at $219K in Q4 2025.
229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.